{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:25:34Z","timestamp":1787509534298,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.vaccine.2011.09.026","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T05:19:09Z","timestamp":1334985549000},"page":"A61-A70","source":"Crossref","is-referenced-by-count":31,"special_numbering":"S1","title":["Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq\u00ae, in Kenya, including among HIV-infected and HIV-exposed infants"],"prefix":"10.1016","volume":"30","author":[{"given":"Kayla F.","family":"Laserson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daveline","family":"Nyakundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Feikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Nyambane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earnest","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Oyieko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Ojwando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Rivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Ciarlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Breiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.09.026_bib0005","first-page":"285","article-title":"Rotavirus vaccines","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis J"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.09.026_bib0015","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/605025","article-title":"Global mortality associated with rotavirus disease among children in 2004","volume":"200","author":"Parashar","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0020","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/j.ijid.2009.06.001","article-title":"Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya","author":"Van Eijk","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0025","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJM199312023292304","article-title":"A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants","volume":"329","author":"Thea","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/00006454-199211120-00002","article-title":"Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic, and epidemiologic features","volume":"11","author":"Pavia","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/tropej\/fmp016","article-title":"Rotavirus infections among HIV-infected children in Nairobi, Kenya","volume":"5","author":"Kiulia","year":"2009","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0040","first-page":"577","article-title":"Intussusception among recipients of rotavirus vaccine\u2014United States, 1998\u20131999","volume":"48","author":"CDC","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/595702","article-title":"Rotarix: a rotavirus vaccine for the world","volume":"48","author":"Ward","year":"2009","journal-title":"CID"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0060","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1201-9712(07)60019-8","article-title":"Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries)","volume":"11","author":"Vesikari","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0065","doi-asserted-by":"crossref","first-page":"G72","DOI":"10.1016\/j.vaccine.2009.09.107","article-title":"Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq\u00ae","volume":"27","author":"Ciarlet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomized, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0080","unstructured":"National AIDS\/STI Control Program (NASCOP), Kenya. 2007 Kenya AIDS Indicator Survey: Final Report. Nairobi, NASCOP, September 2009."},{"key":"10.1016\/j.vaccine.2011.09.026_bib0085","unstructured":"KEMRI\/CDC Research and Public Health ollaboration. KEMRI\/CDC Health and Demographic Surveillance System, 2008 Annual Report. KEMRI\/CDC Research and Public Health Collaboration, Kisumu, Kenya, pp. 1\u201336."},{"key":"10.1016\/j.vaccine.2011.09.026_bib0090","unstructured":"Kenya National Bureau of Statistics (KNBS) and ICF Macro. 2010. Kenya Demographic and Health Survey 2008\u201309. Calverton, Maryland: KNBS and ICF Macro."},{"key":"10.1016\/j.vaccine.2011.09.026_bib0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2003.09.016","article-title":"Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Bines","year":"2004","journal-title":"Vaccine"},{"issue":"December (51\u201352)","key":"10.1016\/j.vaccine.2011.09.026_bib0100","first-page":"533","article-title":"Rotavirus vaccines: an update","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0105","unstructured":"Merck & Co., Inc. Protocol V260-015-04. Efficacy, Safety and Immunogenicity of RotaTeq\u00ae Among Infants in Asia and Africa, 2008."},{"key":"10.1016\/j.vaccine.2011.09.026_bib0110","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/INF.0b013e31815eee0a","article-title":"Risk factors for severe rotavirus gastroenteritis","volume":"27","author":"Huppertz","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.09.026_bib0115","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1086\/605027","article-title":"A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children","volume":"200","author":"Steele","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0120","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(01)05706-3","article-title":"Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children","volume":"358","author":"Cunliffe","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0125","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/JCM.38.8.2873-2877.2000","article-title":"Enteric virus infections and diarrhea in healthy and HIV-infected children","volume":"38","author":"Liste","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/infdis\/169.4.897","article-title":"Association of rotavirus and HIV infection in children hospitalized with acute diarrhea, Lusaka, Zambia","volume":"169","author":"Oshitani","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jama.1994.03510300054038","article-title":"Diarrheal morbidity during the first 2 years of life among HIV-infected infants","volume":"271","author":"Kotloff","year":"1994","journal-title":"JAMA"},{"issue":"June","key":"10.1016\/j.vaccine.2011.09.026_bib0140","first-page":"213","article-title":"Polio vaccines and polio immunization in the pre-eradication era: WHO position paper","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0145","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the advisory committee on immunization practices (ACIP)","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/INF.0b013e3181f42db9","article-title":"Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa","volume":"30","author":"Steele","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.09.026_bib0155","unstructured":"NIAID. Safety and immune response of a rotavirus vaccine in HIV-infected and uninfected children born to HIV-infected mothers. Clin Trial: NCT00880698. Currently recruiting."},{"key":"10.1016\/j.vaccine.2011.09.026_bib0160","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T02:47:58Z","timestamp":1594003678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":32,"alternative-id":["S0264410X11014320"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}